Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients

Early reversal after neostigmine is prompt; however, recovery to a TOF ratio of 0.9 is slow in overweight and obese patients when vecuronium is dosed on the basis of the patient's RBW.